Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients-Reference-Cited by-同舟云学术

Post-transplantation Burkitt lymphoma: a retrospective study of 55 patients

Published:2023-03-09 Issue:10 Volume:108 Page:2814-2819
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Walczak Pierre,Choquet Sylvain,Dantal Jacques,Boutboul David,Suarez Felipe,Baron Marine,Morel Veronique,Cluzeau Thomas,Touati Mohamed,Elias Michelle,Bachy Emmanuel,Nicolas-Virelizier Emmanuelle,Houot Roch,Venton Geoffroy,Jacquet Caroline,Moles-Moreau Marie-Pierre,Jardin Fabrice,Durot Eric,Balegroune Noureddine,Ecotiere Laure,Guieze Romain,Kamar Nassim,Ysebaert Loic,Couzi Lionel,Gonzalez Hugo,Roulin Louise,Ou Kevin,Caillard Sophie,Zimmermann Heiner,Trappe Ralf Ulrich,Roos-Weil Damien

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference15 articles.

1. Dharnidharka VR, Webster AC, Martinez OM. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016; 2:15088.

2. Choquet S, Leblond V, Herbrecht R. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006; 107(8):3053-3057.

3. Trappe R, Oertel S, Leblond V. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012; 13(2):196-206.

4. Trappe RU, Dierickx D, Zimmermann H. Response to rituximab induction is a predictive marker in B-cell post-transplant lymphoproliferative disorder and allows successful stratification into rituximab or R-CHOP consolidation in an international, prospective, multicenter phase II trial. J Clin Oncol. 2017; 35(5):536-543.

5. Zimmermann H, Koenecke C, Dreyling MH. Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell post-transplant lymphoproliferative disorder (PTLD) after solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial. Leukemia. 2022; 36(10):2468-2478.